Refractory/relapsed EBV-related hemophagocytic lymphohistiocytosis

Clinical trials for Refractory/relapsed EBV-related hemophagocytic lymphohistiocytosis explained in plain language.

Never miss a new study

Get alerted when new Refractory/relapsed EBV-related hemophagocytic lymphohistiocytosis trials appear

Sign up with your email to follow new studies for Refractory/relapsed EBV-related hemophagocytic lymphohistiocytosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for kids: drug may shield against dangerous viruses after transplant

Disease control Recruiting now

This study tests whether the drug letermovir can prevent serious viral infections in children with EBV-related blood disorders who receive a stem cell transplant. About 80 children will be enrolled, and researchers will monitor for infections and other transplant complications. T…

Matched conditions: REFRACTORY/RELAPSED EBV-RELATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Sponsor: Beijing Children's Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC

Refractory/relapsed EBV-related hemophagocytic lymphohistiocytosis

Get alerted when new Refractory/relapsed EBV-related hemophagocytic lymphohistiocytosis trials appear

New hope for kids: drug may shield against dangerous viruses after transplant